Skip to content
Clinical Trials – home
IcelandBack to Iceland

Clinical trials in Kopavogur

5 clinical trials in Kopavogur, Iceland. Every trial is listed in the EU Clinical Trials Register and updated daily.

IcelandOur site in IcelandKliniskarRannsoknir.is(opens in a new tab)
Kopavogur at a glance
5
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Kopavogur

Open in trial search
Countries:IcelandIceland
  • Participants:0–17 years
  • Substances:Terbinafine
  • Sponsor:Moberg Pharma AB (publ)
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Dyslipidaemia

Not recruiting
Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Other cities in Iceland

The busiest research cities in the country

All 2 cities in Iceland

Clinical research in Kopavogur

What the registry says about research in the country

01 Cardiovascular Research

Investigating new therapeutic approaches for cardiovascular disease, focusing on innovative treatments to reduce major cardiovascular events in high-risk patients.

  • Lipoprotein Management
  • Cardiovascular Event Prevention
  • Advanced Therapeutics

Studies aim to evaluate novel compounds that target specific cardiovascular risk factors and improve patient outcomes.

02 Atherosclerosis Studies

Clinical research focusing on atherosclerotic cardiovascular disease and innovative approaches to prevent serious cardiovascular complications.

  • Preventive Medicine
  • Lipid Management
  • Vascular Health

Evaluating cutting-edge treatments to reduce the risk of heart attacks, strokes, and cardiovascular mortality.

03 Pediatric Dermatology

Research focusing on treating fungal nail infections in young patients, exploring safe and effective therapeutic solutions for children aged 6-17 years.

  • Pediatric Treatment Safety
  • Topical Therapeutics
  • Clinical Efficacy Assessment

Studies evaluate innovative external treatments designed specifically for younger populations with nail conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.